Licorice flavonoid oil reduces total body fat and visceral fat in overweight subjects: A randomized, double-blind, placebo-controlled study

Obesity Research and Clinical Practice

Volumn 3, Issue 3, 2009, Pages 169-178

  Tominaga, Yuji ^a   Nakagawa, Kaku ^a   Mae, Tatsumasa ^a   Kitano, Mitsuaki ^a   Yokota, Shinichi ^a   Arai, Toshihiro ^b   Ikematsu, Hideyuki ^c   Inoue, Shuji ^d  

^a KANEKA CORPORATION   (Japan)

^b Kaiyuu Clinic   (Japan)

^c Hara Doi Hospital   (Japan)

^d KIRYU UNIVERSITY   (Japan)

Author keywords

Body fat; Body mass index; Flavonoids; Licorice; Visceral fat

Indexed keywords

FLAVONOID; GLABRIDIN; KANEKA GLAVONOID; LICORICE FLAVONOID OIL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BODY FAT; BODY MASS; CALORIC INTAKE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG MEGADOSE; DRUG SAFETY; FEMALE; GLYCYRRHIZA; HUMAN; INTRAABDOMINAL FAT; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WEIGHT REDUCTION;

GLYCYRRHIZA;

EID: 67649479227     PISSN: 1871403X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.orcp.2009.04.005     Document Type: Article

References (27)

1. Seidel J. Epidemiology-definition and classification of obesity. In: Kopelman P.G., Caterson I., and Dietz W.H. (Eds). Clinical obesity in adults and children (2005), Blackwell, Malden, USA 3-11
2. Isomaa B. A major health hazard: the metabolic syndrome. Life Sci 73 19 (2003) 2395-2411
3. Isomaa B., Almgren P., Tuomi T., Forsen B., Lahti K., Nissen M., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 4 (2001) 683-689
4. Zimmet P., Magliano D., Matsuzawa Y., Alberti G., and Shaw J. The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb 12 6 (2005) 295-300
5. Nakagawa K., Kishida H., Arai N., Nishiyama T., and Mae T. Licorice flavonoids suppress abdominal fat accumulation and increase in blood glucose level in obese diabetic KK-A(y) mice. Biol Pharm Bull 27 11 (2004) 1775-1778
6. Aoki F., Honda S., Kishida H., Kitano M., Arai N., Tanaka H., et al. Suppression by licorice flavonoids of abdominal fat accumulation and body weight gain in high-fat diet-induced obese C57BL/6J mice. Biosci Biotechnol Biochem 71 1 (2007) 206-214
7. Kamisoyama H., Honda K., Tominaga Y., Yokota S., and Hasegawa S. Investigation of the anti-obesity action of licorice flavonoid oil in diet-induced obese rats. Biosci Biotechnol Biochem 72 12 (2008) 3225-3231
8. Shibata S. A drug over the millennia: pharmacognosy, chemistry, and pharmacology of licorice. Yakugaku Zasshi 120 10 (2000) 849-862
9. Federation of American Societies for Experimental Biology. Evaluation of the health aspects of Licorice, Glycyrrhiza and ammoniated glycyrrhizin as food ingredients (1974), U.S. Department of Commerce, National Technical Information Service p. 254-529
10. Fuhrman B., Buch S., Vaya J., Belinky P.A., Coleman R., Hayek T., et al. Licorice extract and its major polyphenol glabridin protect low-density lipoprotein against lipid peroxidation: in vitro and ex vivo studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr 66 2 (1997) 267-275
11. Fuhrman B., Volkova N., Kaplan M., Presser D., Attias J., Hayek T., et al. Antiatherosclerotic effects of licorice extract supplementation on hypercholesterolemic patients: increased resistance of LDL to atherogenic modifications, reduced plasma lipid levels, and decreased systolic blood pressure. Nutrition 18 3 (2002) 268-273
12. Vaya J., Belinky P.A., and Aviram M. Antioxidant constituents from licorice roots: isolation, structure elucidation and antioxidative capacity toward LDL oxidation. Free Radic Biol Med 23 2 (1997) 302-313
13. Belinky P.A., Aviram M., Fuhrman B., Rosenblat M., and Vaya J. The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during its oxidation. Atherosclerosis 137 1 (1998) 49-61
14. Fukai T., Marumo A., Kaitou K., Kanda T., Terada S., and Nomura T. Anti-helicobacter pylori flavonoids from licorice extract. Life Sci 71 12 (2002) 1449-1463
15. Fukai T., Satoh K., Nomura T., and Sakagami H. Antinephritis and radical scavenging activity of prenylflavonoids. Fitoterapia 74 7/8 (2003) 720-724
16. Ofir R., Tamir S., Khatib S., and Vaya J. Inhibition of serotonin re-uptake by licorice constituents. J Mol Neurosci 20 2 (2003) 135-140
17. Yokota T., Nishio H., Kubota Y., and Mizoguchi M. The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation. Pigment Cell Res 11 6 (1998) 355-361
18. Nakagawa K., Kitano M., Kishida H., Hidaka T., Nabae K., Kawabe M., et al. 90-Day repeated-dose toxicity study of licorice flavonoid oil (LFO) in rats. Food Chem Toxicol 46 7 (2008) 2349-2357
19. Nakagawa K., Hidaka T., Kitano M., Asakura M., Kamigaito T., Noguchi T., et al. Genotoxicity studies on licorice flavonoid oil (LFO). Food Chem Toxicol 46 7 (2008) 25-32
20. Aoki F., Nakagawa K., Kitano M., Ikematsu H., Nakamura K., Yokota S., et al. Clinical safety of licorice flavonoid oil (LFO) and pharmacokinetics of glabridin in healthy humans. J Am Coll Nutr 26 3 (2007) 209-218
21. Tominaga Y., Mae T., Kitano M., Sakamoto Y., Ikematsu H., and Nakagawa K. Licorice flavonoid oil effects body weight loss by reduction of body fat mass in overweight subjects. J Health Sci 52 6 (2006) 672-683
22. Albanese C.V., Diessel E., and Genant H.K. Clinical applications of body composition measurements using DXA. J Clin Densitom 6 2 (2003) 75-85
23. Erselcan T., Candan F., Saruhan S., and Ayca T. Comparison of body composition analysis methods in clinical routine. Ann Nutr Metab 44 5/6 (2000) 243-248
24. Fujioka S., Matsuzawa Y., Tokunaga K., and Tarui S. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 36 (1987) 45-59
25. Aoki F., Nakagawa K., Tanaka A., Matsuzaki K., Arai N., and Mae T. Determination of glabridin in human plasma by solid-phase extraction and LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 828 1/2 (2005) 70-74
26. Wang Y.M., Nagao K., Inoue N., Ujino Y., Shimada Y., Nagao T., et al. Isomer-specific anti-obese and hypolipidemic properties of conjugated linoleic acid in obese OLETF rats. Biosci Biotechnol Biochem 70 2 (2006) 355-362
27. Stormer F.C., Reistad R., and Alexander J. Glycyrrhizic acid in liquorice-evaluation of health hazard. Food Chem Toxicol 31 4 (1993) 303-312